Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

239 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Hypermethylation analysis of mismatch repair genes (hmlh1 and hmsh2) in locally advanced breast cancers in Indian women.
Naqvi RA, Hussain A, Deo SS, Kukreti H, Chauhan M, Sarin R, Saxena A, Asim M, Shukla NK, Husain SA, Pasha ST, Basir SF. Naqvi RA, et al. Hum Pathol. 2008 May;39(5):672-80. doi: 10.1016/j.humpath.2007.09.011. Epub 2008 Mar 10. Hum Pathol. 2008. PMID: 18329696
Specific 50'CpG island methylation signatures of FHIT and p16 genes and their potential diagnostic relevance in Indian breast cancer patients.
Naqvi RA, Hussain A, Raish M, Noor A, Shahid M, Sarin R, Kukreti H, Khan NJ, Ahmad S, Deo SV, Husain SA, Pasha ST, Basir SF, Shukla NK. Naqvi RA, et al. DNA Cell Biol. 2008 Sep;27(9):517-25. doi: 10.1089/dna.2007.0660. DNA Cell Biol. 2008. PMID: 18593338
Prognostic significance of cytoplasmic S100A2 overexpression in oral cancer patients.
Kumar M, Srivastava G, Kaur J, Assi J, Alyass A, Leong I, MacMillan C, Witterick I, Shukla NK, Thakar A, Duggal R, Roychoudhury A, Sharma MC, Walfish PG, Chauhan SS, Ralhan R. Kumar M, et al. J Transl Med. 2015 Jan 16;13:8. doi: 10.1186/s12967-014-0369-9. J Transl Med. 2015. PMID: 25591983 Free PMC article.
Heterogeneous ribonucleoprotein K is a marker of oral leukoplakia and correlates with poor prognosis of squamous cell carcinoma.
Matta A, Tripathi SC, DeSouza LV, Grigull J, Kaur J, Chauhan SS, Srivastava A, Thakar A, Shukla NK, Duggal R, DattaGupta S, Ralhan R, Michael Siu KW. Matta A, et al. Int J Cancer. 2009 Sep 15;125(6):1398-406. doi: 10.1002/ijc.24517. Int J Cancer. 2009. PMID: 19548310
End Binding 1 (EB1) overexpression in oral lesions and cancer: A biomarker of tumor progression and poor prognosis.
Kumar M, Mehra S, Thakar A, Shukla NK, Roychoudhary A, Sharma MC, Ralhan R, Chauhan SS. Kumar M, et al. Clin Chim Acta. 2016 Aug 1;459:45-52. doi: 10.1016/j.cca.2016.05.012. Epub 2016 May 18. Clin Chim Acta. 2016. PMID: 27208742
Nuclear heterogeneous nuclear ribonucleoprotein D is associated with poor prognosis and interactome analysis reveals its novel binding partners in oral cancer.
Kumar M, Matta A, Masui O, Srivastava G, Kaur J, Thakar A, Shukla NK, RoyChoudhury A, Sharma M, Walfish PG, Michael Siu KW, Chauhan SS, Ralhan R. Kumar M, et al. J Transl Med. 2015 Aug 30;13:285. doi: 10.1186/s12967-015-0637-3. J Transl Med. 2015. PMID: 26318153 Free PMC article.
Skewed immunological balance between Th17 (CD4(+)IL17A (+)) and Treg (CD4 (+)CD25 (+)FOXP3 (+)) cells in human oral squamous cell carcinoma.
Gaur P, Qadir GA, Upadhyay S, Singh AK, Shukla NK, Das SN. Gaur P, et al. Cell Oncol (Dordr). 2012 Oct;35(5):335-43. doi: 10.1007/s13402-012-0093-5. Epub 2012 Sep 7. Cell Oncol (Dordr). 2012. PMID: 22956260
Loss of DLC1 is an independent prognostic factor in patients with oral squamous cell carcinoma.
Tripathi SC, Kaur J, Matta A, Gao X, Sun B, Chauhan SS, Thakar A, Shukla NK, Duggal R, Choudhary AR, DattaGupta S, Sharma MC, Ralhan R, Siu KW. Tripathi SC, et al. Mod Pathol. 2012 Jan;25(1):14-25. doi: 10.1038/modpathol.2011.145. Epub 2011 Oct 14. Mod Pathol. 2012. PMID: 22002576
Nuclear S100A7 is associated with poor prognosis in head and neck cancer.
Tripathi SC, Matta A, Kaur J, Grigull J, Chauhan SS, Thakar A, Shukla NK, Duggal R, DattaGupta S, Ralhan R, Siu KW. Tripathi SC, et al. PLoS One. 2010 Aug 3;5(8):e11939. doi: 10.1371/journal.pone.0011939. PLoS One. 2010. PMID: 20689826 Free PMC article.
239 results
Jump to page